MRA Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$608K Sell
1,441
-2,815
-66% -$1.12M 0.23% 67
2026
Q2
$1.54M Buy
4,256
+3,454
+431% +$1.18M 0.56% 44
2026
Q1
$282K Buy
802
+2
+0.3% +$713 0.12% 104
2025
Q4
$262K Sell
800
-264
-25% -$83.7K 0.11% 106
2025
Q3
$300K Buy
1,064
+69
+7% +$20K 0.13% 99
2025
Q2
$278K Sell
995
-313
-24% -$88.7K 0.13% 103
2025
Q1
$407K Buy
1,308
+275
+27% +$81.2K 0.22% 66
2024
Q4
$269K Buy
1,033
+111
+12% +$32.9K 0.14% 80
2024
Q3
$297K Buy
922
+1
+0.1% +$327 0.16% 70
2024
Q2
$288K Buy
+921
New +$271K 0.16% 73
2023
Q4
– Sell
-974
Closed -$262K – 110
2023
Q3
$262K Sell
974
-370
-28% -$92.3K 0.19% 95
2023
Q2
$298K Buy
+1,344
New +$312K 0.21% 85

Other funds holding AMGN

MRA Advisory Group's AMGN Position: Q3 2026 in Review

MRA Advisory Group reduced its Amgen (AMGN) stake by 66% in Q3 2026, selling an estimated $1.12M and leaving 1,441 shares worth $608K. The position accounts for 0.23% of the portfolio, ranked #67.

MRA Advisory Group first reported a position in AMGN in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.54M in Q2 2026. 1,418 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • MRA Advisory Group held 1,441 shares of Amgen worth $608K as of Q3 2026.
  • MRA Advisory Group sold 2,815 Amgen shares in Q3 2026, an estimated $1.12M.
  • Amgen made up 0.23% of MRA Advisory Group's portfolio in Q3 2026, its #67 holding.
  • MRA Advisory Group first reported a position in Amgen in Q2 2023 and has held it in 12 quarters since.
  • MRA Advisory Group's Amgen position peaked at $1.54M in Q2 2026.
  • 1,418 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on MRA Advisory Group's 13F filing for Q3 2026, filed 7 Oct 2026.